Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 December 2023 | Story Leonie Bolleurs | Photo Supplied
3D-Printed Sculptural Artefact
The 3D-printed sculptural artefact entered by a group of third-years from the UFS.

A group of third-year students from the UFS Department of Architecture exhibited their work at the 2023 Venice Biennale, an international architecture exhibition showcasing ground-breaking architectural work from various countries around the world.

The contributions of world-class architects, researchers, and institutions in architecture are exhibited at this exhibition. “To be featured in this exhibition means that we are recognised by the international community as one of the leading architectural learning sites in South Africa and the work being produced at the institution deserves international acclaim,” says Phadi Mabe, Lecturer in the department.

The students representing the university with Mabe and participating in this event are Anya Strydom, Yamkelwa Simelane, Jan Truter, and Khalipha Radebe.

Mabe says the artefact produced from this project is a 3D-printed sculptural device that shows the translation between sound and object and illustrates the sound data through 3D-printed forms. “The sound structures of South Africa’s languages are mapped three-dimensionally to create a visual and spatial record of language. This unique artefact demonstrates that there are uncharted terrains in architecture, suggesting alternative dimensions that can be extrapolated to show that architecture can represent the intangible” he explains.

The UFS artefact was one of six design artefacts selected for the 18th International Architecture Exhibition – La Biennale di Venezia, which opened to the public in May and closes on 26 November 2023.

Hosted by the Department of Sport, Arts and Culture, the competition involved an emphasis on students incorporating African traditional architecture into their design models.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept